Jennifer Kinsbruner Bush's most recent trade in Artiva Biotherapeutics Inc was a trade of 117,300 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 117,300 | 350,225 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 3,515 | 346,710 | - | 4 | 14,060 | Common Stock |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 84,877 | 232,925 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 41,039 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 14,202 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 9,119 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 3,055 | 148,048 | - | 3.3 | 9,929 | Common Stock |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 6,409 | 151,103 | - | 2.8 | 17,625 | Common Stock |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 1,937 | 157,512 | - | 2.1 | 4,126 | Common Stock |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 86,650 | 159,449 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 50,000 | 72,799 | - | 0 | Common Stock |